DNA Cancer and Inherited Disease Assessment

Contact us to find out more

The importance of healthcare planning and risk assessment.

Cancer is one of the leading causes of death. In Hong Kong, cancer is the number one killer, accounting for 30.5% of all registered deaths in 2016. Likewise, in China, close to 20% of the total population is at risk of developing cancer before the age of 75.

Poor diet, lifestyle and psychological stress can also bring about the early onset of cancers. However, a healthy diet and lifestyle don’t always prevent cancer.

Sometimes, it is genetics. Understanding and assessing your level of cancer risk and that of your family can lead to a better health management and planning. Remember, detecting cancer early saves lives, and most cases of cancer are preventable.

As a one-stop financial platform, we work seamlessly with our group companies and benefited from their individual capabilities.

Halena Ng, Chairman and Chief Executive Officer


DNA Cancer and Inherited Disease Assessment

  • These tests cover most kinds of cancers, including the top killers in Hong Kong and China.
  • A way to more effectively and efficiently understand your own health and that of your partner and your families, including any critical illness risks.
  • Allows for self-planning and family planning at an early stage.
  • Prevention is better than cure.
ctDN Cancer and Inherited Disease Assessment
  • ctDNA Early Cancer Screening
  • Male: 38 types
  • Female: 42 types
  • Early Stage Nasopharyngeal Cancer Screening
  • Report Consultation by certified genetic counsellor
Circulating tumour DNA (ctDNA)
  • Detected items: 44 types of cancer
  • Monitoring for cancer recurrence: Can assess the risk of cancer recurrence up to 6 months
  • Testing limitation(s): No current limit
Epstein-Barr Virus DNA for early detection of nasopharyngeal cancer
  • Targeting: EBV DNA
  • Sensitivity: 97.1%
  • Early Nasopharyngeal cancer detection rate: 75%
Cancer Predisposition

Cancer Predisposition is an increased likelihood of developing a certain cancer type due to a person’s genetic makeup. Early screening allows for identification of a person’s cancer risk profile so that they can make relevant lifestyle changes or prepare care management in response to this risk. 

Carrier Testing

Carrier Testing is used to identify individuals who carry one copy of a specific gene mutation that, when present in two copies, can cause a genetic disorder. The test is useful in assessing a couple’s risk of having a child with a genetic condition.

About Pangenia Group
Founded by Professor Joseph Wing-On Tam in 2006, Pangenia Group is one of Hong Kong’s largest biotech companies specializing in molecular diagnostics (MDx). The company has analysed more than 700,000 clinical samples in their own laboratory, and it is the first independent private laboratory to get a license for pre-implantation genetic screening services in Hong Kong.
Click to visit Pangenia's website
Do you know...

Who should be considered for testing?

  • Who wish to uncover genetic makeup

    Individuals or couples who wish to uncover their genetic makeup for certain inherited conditions and cancer predisposition.

  • Who has family history of inherited diseases

    Individuals or couples who have a family history of inherited diseases, or multiple family members who have been diagnosed with certain cancers.

  • Who is doing family planning

    Carrier testing for couples in family planning and for infertile couples.

  • Cancer victims


    Cancer victims in order to assess any additional cancer risks.

whats next

Start the conversation


Feel free to contact us by email or phone.

Get in touch